Aptar Pharma is pleased to be exhibiting at CPhI North America 2019, taking place on April 30–May 2 at McCormick Place in Chicago, Illinois.
At Booth 1721, Aptar Pharma experts will be on hand to present our diverse portfolio of drug delivery systems, services and active packaging solutions, as well as our latest innovations including:
- Our Bidose nasal drug delivery device, recently approved by the U.S. FDA for a breakthrough treatment of depression
- Our industry award-winning Aptar Pharma QuickStart™ Injectables – our Ready-to-Use drug development support package designed to accelerate time-to-market for research and development labs
- Our recently launched PureHale – a portable and ready-to-use device designed to deliver natural care to upper airways
Also, discover Aptar Pharma’s expanded range of connected drug delivery devices, demonstrating our investment in the future of digital medicines, at CPhI North America 2019. Talk to our experts about our active packaging solutions portfolio from Aptar CSP Technologies, now part of the Aptar family, helping to optimize your drug product’s packaging environment.
Find out how Aptar Pharma is expanding its North America manufacturing to be closer to customers. Equipped with the latest technologies to meet growing quality requirements for regulated markets, our recently expanded capabilities at our Congers, NY site will continue to deliver solutions to our customers’ drug delivery challenges.
CPhI North America expects to welcome more than 6,500 industry professionals this year. During this three-day event, leaders from across the pharma supply chain will gather to exchange ideas, build partnerships and shape the future of the field.
Find out more: New drug delivery solutions from Aptar Pharma at CPhI North America..
